Cure for relapsed/refractory disease need to be made a decision depending on prior therapy in addition to the reason why the initial procedure was no longer ideal (e.g., refractoriness vs. intolerance). Ibrutinib is the current gold standard therapy for people with relapsed/refractory condition, according to the outcome of a number of section I-III